Cite
HARVARD Citation
Saad, A. et al. (2022). Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone. Thoracic cancer. 13 (12), pp. 1763-1771. [Online].